CSG Actuarial has added a new Medicare Supplement Health Condition and Medication Underwriting Filter to the MarketAdvisor quoting tool which will display carriers that will accept selected health conditions and medications. The table below is a sample of medications declined by the top Medicare Supplement carriers.
| Medication | % of Companies that Decline | Conditions Associated with Medication |
|---|---|---|
| Abilify | 60% | Bipolar Disorder, Depression, Psychosis, Schizophrenia |
| Betapace | 30% | Arrhythmias, Atrial Fibrillation |
| Cerefolin | 60% | Alzheimer's Disease, Dementia |
| Copaxone | 80% | Multiple Sclerosis |
| Disulfiram | 40% | Alcoholism |
| Dolophine | 30% | Opioid Analgesic, Opioid Dependence, Severe Pain |
| Enbrel | 50% | Plaque Psoriasis, Rheumatoid Arthritis |
| Humira | 45% | Crohn's Disease, Rheumatoid Arthritis |
| Insulin | 70% | Diabetes |
| Kadian | 25% | Chronic or Severe Pain |
| L-Dopa | 85% | Parkinson’s Disease |
| Letairis | 50% | Cancer, Pulmonary Hypertension |
| Natrecor | 55% | Congestive Heart Failure |
| Plavix | 40% | Angioplasty, Blood Thinner, Stroke, Stroke Prevention |
| Rilutek | 70% | ALS/Lou Gehrig’s Disease |
| Trizivir | 65% | AIDS, HIV |
| Viadur | 35% | Cancer, Prostate Cancer |
About CSG Actuarial
CSG Actuarial monitors insurance markets to provide the most up-to-date competitive intelligence in the industry. CSG’s MarketAdvisor™ Quoting Tools include premium rate and underwriting information for more than 300 companies.
To learn more, contact our sales team at 855-861-8776 or info@csgactuarial.com, or schedule your demo here.